Trials (Institut Curie): Revision history

14 December 2025

• curprev 18:3718:37, 14 December 2025‎ Francine talk contribs‎ 87,610 bytes +165‎ No edit summary undo

6 December 2025

• curprev 12:4112:41, 6 December 2025‎ Lucas talk contribs‎ m 87,445 bytes +1,701‎ Update categories. undo

2 December 2025

• curprev 20:4520:45, 2 December 2025‎ Francine talk contribs‎ 85,744 bytes +7‎ No edit summary undo
• curprev 13:5913:59, 2 December 2025‎ Lucas talk contribs‎ m 85,737 bytes +11,373‎ Update categories. undo

6 November 2024

• curprev 17:0917:09, 6 November 2024‎ Victor talk contribs‎ 74,364 bytes +31‎ No edit summary undo
• curprev 15:5815:58, 6 November 2024‎ Victor talk contribs‎ 74,333 bytes +11‎ No edit summary undo

4 January 2024

• curprev 16:4716:47, 4 January 2024‎ Francine talk contribs‎ 74,322 bytes +1,253‎ No edit summary undo

1 December 2023

• curprev 21:5821:58, 1 December 2023‎ Francine talk contribs‎ 73,069 bytes +73,069‎ Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Institut Curie page '''NCTID''': NCT03875573 '''Title''': Neo-adjuvant Chemotherapy Combined With Stereotactic Body Radiotherapy to the Primary Tumour +/- Durvalumab, +/- Oleclumab in Luminal B Breast Cancer: '''Study Summary''': Neo-CheckRay is a multicenter, open-label phase II study that randomizes luminal B breast cancer subjects candidate for neo-adjuvant chemotherapy in a 1:1:1 ratio in 3 arms:..."